TN2010000391A1 - Surface modified micronized tacrolimus crystalline particles and pharmaceutical compositions thereof - Google Patents

Surface modified micronized tacrolimus crystalline particles and pharmaceutical compositions thereof

Info

Publication number
TN2010000391A1
TN2010000391A1 TNP2010000391A TN2010000391A TN2010000391A1 TN 2010000391 A1 TN2010000391 A1 TN 2010000391A1 TN P2010000391 A TNP2010000391 A TN P2010000391A TN 2010000391 A TN2010000391 A TN 2010000391A TN 2010000391 A1 TN2010000391 A1 TN 2010000391A1
Authority
TN
Tunisia
Prior art keywords
surface modified
pharmaceutical compositions
crystalline particles
micronized tacrolimus
modified micronized
Prior art date
Application number
TNP2010000391A
Other languages
French (fr)
Inventor
Boujbel Lassaad
Amine Boujbel Mohamed
Lukas Stephen
Ren Karel
Original Assignee
Medis Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medis Lab filed Critical Medis Lab
Priority to TNP2010000391A priority Critical patent/TN2010000391A1/en
Publication of TN2010000391A1 publication Critical patent/TN2010000391A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical composition comprising surface modified micronized tacrolimus crystalline particles having d90 value of from 2 µm to 10 µm.
TNP2010000391A 2010-08-25 2010-08-25 Surface modified micronized tacrolimus crystalline particles and pharmaceutical compositions thereof TN2010000391A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TNP2010000391A TN2010000391A1 (en) 2010-08-25 2010-08-25 Surface modified micronized tacrolimus crystalline particles and pharmaceutical compositions thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TNP2010000391A TN2010000391A1 (en) 2010-08-25 2010-08-25 Surface modified micronized tacrolimus crystalline particles and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
TN2010000391A1 true TN2010000391A1 (en) 2011-12-29

Family

ID=54696139

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000391A TN2010000391A1 (en) 2010-08-25 2010-08-25 Surface modified micronized tacrolimus crystalline particles and pharmaceutical compositions thereof

Country Status (1)

Country Link
TN (1) TN2010000391A1 (en)

Similar Documents

Publication Publication Date Title
WO2011098582A3 (en) Novel crystalline forms of ivabradine hydrochloride
IL216911A (en) Diketopiperazine microparticles with defined specific surface areas of from 40 to 67 m2/gram and compositions containing same
WO2011107186A3 (en) Compounds for electronic devices
IL220939A (en) Compounds for the inhibition of hdac and pharmaceutical compositions comprising them
MX353145B (en) Apixaban formulations.
IL222199A0 (en) Process for preparation of dopo-derived compounds and compositions thereof
MX2010014041A (en) A crystalline form of posaconazole.
EP2217225A4 (en) Pharmaceutical composition containing micronized particles of naphthoquinone-based compound
IL221396A (en) Compositions for delivering oligonuleotides to liver cells and methods for manufacturing same
CA2818187C (en) Bromodomain inhibitors and uses thereof
IL224288A (en) Derivatives of substituted pyrazolamide, pharmaceutical compositions comprising the same and uses thereof
ZA201208265B (en) Pharmaceutical compositions and methods of making same
IL232515A0 (en) Nadph oxidase 4 inhibitors and pharmaceutical compositions containing the same
WO2011131943A3 (en) Pharmaceutical compositions
RS56180B1 (en) Fly ash processing and manufacture of articles incorporating fly ash compositions
PL2598500T3 (en) Compositions and methods for inhibition of the jak pathway
IL223000A0 (en) Posology and administration of glucocorticoid based compositions
WO2013057741A3 (en) Pharmaceutical compositions of ursodeoxycholic acid
PL2582359T3 (en) Solid compositions in form of powders or granulates for the oral administration of active ingredients and method for obtaining them
WO2011045760A3 (en) Micronized olmesartan medoxomil compositions
ZA201207688B (en) Compositions and methods for non-toxic delivery of antiprogestins
WO2012025828A3 (en) Superfine powdered stevia
HK1188911A1 (en) Composition of purified soluble mannans for dietary supplements and methods of use thereof
MX2013013079A (en) Compositions comprising antibacterial agent and tazobactam.
WO2014167579A3 (en) Stable pharmaceutical compositions of tadalafil